An underground economy for unapproved slimming drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.
Experimental Treatment Acquiring Traction Via Social Media
Retatrutide, which remains in clinical trials, is being advertised by online personalities for its alleged fat-burning effects. Followers are urged to message these profiles directly for source information, while also obtaining discount codes.
Thriving Trade on Social Networks
Separately, a robust trade exists on Telegram, where communities with thousands of participants share “before and after” photos, injection guides and assertions of rapid British shipping. Sellers market the drug there before redirecting buyers to other platforms for purchases.
Learning About The Experimental Drug
This medication is an investigational injection created by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials indicate it could help individuals reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being promoted digitally as the successor to Ozempic.
Medical Experts Express Concerns
However, doctors and pharmacists have warned that the distribution of what remains an unlicensed medication in the United Kingdom is worrisome and could lead to individuals injecting products of uncertain source.
Several professionals said the demand for the experimental drug could be connected to the increasing cost of approved slimming products such as Mounjaro.
Regulatory Status and Implementation
Selling retatrutide on social media or messaging apps is illegal in the UK, as it is an unapproved drug that must not be marketed or distributed for human use under the British medical regulations.
Some content creators try to sidestep the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and supply can still violate medicines, marketing, and consumer regulations, risking penalties, prosecution or imprisonment.
Platform Response and Material Removal
Based on TikTok, the service has taken down problematic material and prohibited associated keywords and query recommendations. The company said it was committed to keeping the service safe and allocating resources in strengthening enforcement strategies.
Online Trading Operations
Research also found communities with up to 9,000 participants selling retatrutide using the platform's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” instantly displays groups with thousands of members, filled with photos of weight loss, positive testimonials and step-by-step instructions for preparing or administering at residence.
Within moments of joining one group, a vendor shared contact information, where most purchases occur. The seller sent an instruction manual and guaranteed delivery within two days. When questioned whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one inquired about weight, medical conditions or previous experience.
Item Information and Pricing
Inside these groups, messages display dark colored parcels with Royal Mail stickers, stating to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, prepared at residence with purified liquid, or pre-filled injectors usually priced at £160 for 20 milligrams. When asked how long a pen should be used, vendors give conflicting answers ranging from a several days to “depends on your body”.
Platform Oversight and Security Actions
A representative for Telegram said it regularly monitored dangerous material on its platform including material that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Warnings
“Individuals are administering materials they can’t verify. Even if the science behind this drug is valid, these online versions may not contain what they claim,” stated a pharmacy expert, the head of pharmaceutical services at Chemist4U.
A medical professional of Asda Online Doctor connected the surge in interest to recent cost increases for authorized slimming drugs such as Mounjaro. “With prices increasing, patients are using social media. But fake treatments are extremely risky. You cannot know what’s contained or whether the environment they were produced in was clean,” she said.
Her staff has previously seen patients injured by self-injection from unconfirmed sources. “We recognize the disappointment, but purchasing from Telegram or WhatsApp is taking chances with your health,” said Wyllie. “These materials could be impure or incorrectly dosed.”
Manufacturer Statement
A representative from Eli Lilly stated the substance was in third stage clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this point no one can sell [it] for personal consumption,” they explained, adding that any item “misleadingly claiming itself as a company experimental substance not yet approved … may expose users to possibly serious medical dangers”.
